Listings

$29 Million EBITDA COVID Testing Lab & Vaccination Business Based in the Midwest

Medical Labs
$60,000,000
XYLAB1A

American HealthCare Capital is pleased to introduce a COVID Testing Lab and Vaccination
Service company for sale in the Midwest. This company was founded in 2020 as a spinoff of a
larger genomics based personalized medicine company. A large portion of their business is
currently derived from local contracts.

The company’s services are provided on a 100% cash basis. Gross Revenues in 2020 were
$12,142,236 with an EBITDA of $4.7 million. In 2021 through Q3, Gross Revenues are at
$44,125,159 with an EBITDA of $21.5 million. At this pace of growth, 2021 will likely see Gross
Revenues north of $60 million and an EBITDA in the neighborhood of $29 million.

Opportunities for growth exist with the expansion of vaccine approval to ages 5 – 11, coupled with
recent government mandates requiring vaccinations. Additionally, given their ability to scale and
service, opportunities are available to leverage current relationships to potentially diversify their
lab offerings, as well as pursue business with large private employers and institutions.
Services are delivered via thousands of independent contractors on site at contracted locations.

The Founder is looking to exit to focus on other businesses but has in place the contracts,
framework, and leadership to continue running the company.

All reasonable offers will be considered.



If you would like to learn more, please use the form on the right-hand side of the page to execute our NDA. You will need to copy the Listing Code and Listing Title from the summary above to complete the NDA.